NasdaqGM - Nasdaq Real Time Price USD
Protara Therapeutics, Inc. (TARA)
3.9400
+0.0900
+(2.34%)
At close: April 22 at 4:00:00 PM EDT
4.1493
+0.21
+(5.31%)
Pre-Market: 8:57:43 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-35,808
-35,808
-37,557
-26,457
-34,502
Investing Cash Flow
19,155
19,155
53,107
14,950
-98,194
Financing Cash Flow
139,865
139,865
-91
-90
-228
End Cash Position
163,543
163,543
40,331
24,872
36,469
Capital Expenditure
-63
-63
-45
-120
-596
Issuance of Capital Stock
136,006
136,006
--
--
--
Repurchase of Capital Stock
--
--
-91
-90
-228
Free Cash Flow
-35,871
-35,871
-37,602
-26,577
-35,098
12/31/2021 - 10/22/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LRMR Larimar Therapeutics, Inc.
2.3800
+18.41%
IMUX Immunic, Inc.
1.0000
+1.10%
CGON CG Oncology, Inc.
20.48
+0.34%
BCAX Bicara Therapeutics Inc.
13.82
+9.25%
INZY Inozyme Pharma, Inc.
1.0300
+5.17%
TECX Tectonic Therapeutic, Inc.
19.49
+8.76%
XENE Xenon Pharmaceuticals Inc.
36.73
+5.85%
URGN UroGen Pharma Ltd.
10.05
+4.04%
STOK Stoke Therapeutics, Inc.
9.22
+7.08%
EWTX Edgewise Therapeutics, Inc.
13.53
+1.73%